# STAQ Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/staq-pharma

- Industry: Pharmaceuticals
- Headquarters: Colorado Springs, US
- Website: www.staqpharma.com
- Latest round: Series C (Mar 2, 2022)
- Investors on record: 7

## About

Based in Colorado, US, and founded in 2010, STAQ Pharma, Inc. engages in the production and distribution of sterile injectable medications. In March 2022, the firm raised a Series C funding co-led by new investors Froedtert Health, UNC Health, and LCMC Health, with participation from other investors. As of 2022, STAQ Pharma, Inc. is being led by its CEO, Joe Bagan, and operates an FDA (Food and Drug Administration) registered 503B outsourcing facility.

The company manufactures and provides FDA-approved sterile-to-sterile and ‘non-sterile to sterile compounded medications that meet the cGMP (Current Good Manufacturing Practices) standards of the pharmaceutical industry.

STAQ Pharma, Inc. intends to use the March 2022 funding to support its expansion plans to build a second facility in Columbus. The company also intends to employ approximately 300 employees at this facility.

## Funding rounds

- Series C, Mar 2, 2022 — Cincinnati Children's Hospital Medical Center, University Hospitals, Rev1 Ventures, Froedtert Health, UNC Health Care, Louisiana Children's Medical Center, Nationwide Children's Hospital

## Investors

- Cincinnati Children's Hospital Medical Center — Series C
- University Hospitals — Series C
- Rev1 Ventures (https://capitalatlas.ai/funds/rev1-ventures) — Series C
- Froedtert Health — Series C
- UNC Health Care — Series C
- Louisiana Children's Medical Center — Series C
- Nationwide Children's Hospital — Series C